Cooperative Agreement IDSEP230059

The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $40.4 million cooperative agreement to Exela Pharma Sciences, LLC (Exela) to expand industrial base capabilities for COVID-19 response. With a period of performance from May 2022 through May 2034, this cooperative agreement will support Exela under the Research on Chemical and Biological Defense program (CFDA 12.360). Through this cooperative agreement, Exela will further the government's...

This Cooperative Agreement award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $1,000,000 in funding to the Virginia Biotechnology Research Park Corporation (dba Activation Capital) to develop a robust pharmaceutical cluster program called the Alliance for Building Better Medicine in the Richmond/Petersburg region of Virginia. Over an 18-month period, the awardee will work with 23 core partners, including three direct...

This $19.75 million Project Grant from the Department of Commerce Economic Development Administration's Economic Adjustment Assistance program will support the expansion of Virginia's domestic pharmaceutical supply chain. Funded initiatives include developing over 19,000 square feet of new wet lab space in Central Virginia to grow pharmaceutical manufacturing capacity. Infrastructure investments in Petersburg will sustain existing industrial operations. Engagement with local businesses will...

This $8.8 million Economic Development Administration Project Grant will support the Advanced Pharmaceutical Manufacturing Cluster led by the Virginia Biotechnology Research Partnership Authority to boost Virginia's domestic pharmaceutical supply chain. Funded projects include expanding wet lab space in Central Virginia to develop a pharmaceutical manufacturing corridor and critical infrastructure investments in Petersburg. The award will also catalyze a partnership between Virginia Commonwealth...

This $24.5 million Economic Development Administration Project Grant supports the Advanced Pharmaceutical Manufacturing Cluster led by the Virginia Biotechnology Research Partnership Authority to boost Virginia's domestic pharmaceutical supply chain. Funded projects will expand wet lab space and critical infrastructure in Central Virginia to develop an emerging pharmaceutical manufacturing corridor and engage local businesses to enhance the regional supply chain. The investment will also...

This Cooperative Agreement awarded by the Department of Defense's Office of the Secretary of Defense under the Procurement Technical Assistance For Business Firms program (CFDA 12.002) provides $163,559.76 to establish and maintain an APEX Accelerator. The APEX Accelerator will serve as a resource for business entities, including newly started businesses, to obtain procurement technical assistance. This assistance enables clients to identify potential contracting opportunities and obtain or...

This $1,000,000 Cooperative Agreement award from the National Science Foundation's (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program aims to accelerate R&D in the pharmaceutical industry through the development of streamlined machine learning algorithms for small data applications in advanced manufacturing. The project, awarded to Sunthetics Inc., seeks to save time and resources by up to 95% in lead optimization and route scouting during pre-clinical drug development by...

The Acadiana Planning Commission, Inc. received a $625,000 Project Grant award from the Department of Commerce Economic Development Administration on May 10, 2022. The funding supports the creation of a strategic plan under the EDA's Economic Adjustment Assistance program to develop a biopharmaceutical manufacturing cluster in Lafayette, Louisiana. The strategic plan will leverage existing and planned facilities and resources in the Acadiana region to increase bio-pharma productivity through...

This $3.19 million Economic Development Administration Project Grant supports the Advanced Pharmaceutical Manufacturing Cluster led by the Virginia Biotechnology Research Partnership Authority to boost Virginia's domestic pharmaceutical supply chain. Funded projects will expand wet lab space in Central Virginia, develop infrastructure in Petersburg, and engage local businesses to enhance the regional supply chain. The award will also catalyze a new partnership between Virginia Commonwealth...

This Cooperative Agreement award of $999,109 from the National Science Foundation (NSF) under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) supports the development of a novel drug discovery platform by Cryptyx Bioscience, Inc. The platform utilizes high-throughput elicitor screening to activate otherwise cryptic biosynthetic pathways in microbes, enabling the discovery of novel microbial natural products with therapeutic or commercial potential. This approach aims...